|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.90 CHF | -0.50% |
|
+1.71% | -50.10% |
| 07-03 | Newron Pharmaceuticals to Make Changes to Phase 3 Trial of Schizophrenia Treatment | MT |
| 05-05 | Edison Is Not Overly Concerned About a Trial Suspension |  |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 12.2 | 15.5 | 30.4 |
| Spread/Res. | -2.46% | -23.23% | -60.86% |
| Spread/Supp. | +4.57% | +4.57% | +32.96% |
| Support | 11.38 | 11.38 | 8.95 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- NWRN Stock
- Charts Newron Pharmaceuticals S.p.A.
Select your edition
All financial news and data tailored to specific country editions
